SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018)
SELLAS Life Sciences (SLS) posted quarterly Preferred Dividend Payments of $2.5 million for Q2 2018, up 25.41% quarter-over-quarter from $2.0 million in Q1 2018.
SELLAS Life Sciences (SLS) Preferred Dividend Payments (2018) Analysis & Trends
SELLAS Life Sciences (SLS) has reported Preferred Dividend Payments for 1 consecutive years, with $2.5 million the latest figure, recorded in Q2 2018.
- In Q2 2018, Preferred Dividend Payments changed N/A year-over-year to $2.5 million; the TTM figure through Mar 2019 stood at $2.5 million (up 25.41% YoY), while the FY2018 annual figure was $4.4 million, changed N/A from the prior year.
- Preferred Dividend Payments improved to $2.5 million in Q2 2018 per SLS's latest filing, from $2.0 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $2.5 million in Q2 2018 and bottomed at $2.0 million in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 2.47 Mn |
| Mar 31, 2018 | 1.97 Mn |